<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:24:56Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9554702" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9554702</identifier>
        <datestamp>2022-10-26</datestamp>
        <setSpec>jamasd</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">JAMA Netw Open</journal-id>
              <journal-id journal-id-type="iso-abbrev">JAMA Netw Open</journal-id>
              <journal-title-group>
                <journal-title>JAMA Network Open</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2574-3805</issn>
              <publisher>
                <publisher-name>American Medical Association</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9554702</article-id>
              <article-id pub-id-type="pmcid">PMC9554702</article-id>
              <article-id pub-id-type="pmc-uid">9554702</article-id>
              <article-id pub-id-type="pmid">36219444</article-id>
              <article-id pub-id-type="pmid">36219444</article-id>
              <article-id pub-id-type="doi">10.1001/jamanetworkopen.2022.35989</article-id>
              <article-id pub-id-type="publisher-id">zoi221015</article-id>
              <article-id pub-id-type="publisher-id">zoi221015</article-id>
              <article-categories>
                <subj-group subj-group-type="category" specific-use="electronic">
                  <subject>Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Investigation</subject>
                </subj-group>
                <subj-group subj-group-type="online-only">
                  <subject>Online Only</subject>
                </subj-group>
                <subj-group subj-group-type="subject-area">
                  <subject>Pediatrics</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Neurocognitive Outcomes at Age 2 Years After Neonatal Hypoglycemia in a Cohort of Participants From the hPOD Randomized Trial</article-title>
                <alt-title alt-title-type="headline">Neurocognitive Outcomes at Age 2 Years After Neonatal Hypoglycemia</alt-title>
                <alt-title alt-title-type="running-head">Neurocognitive Outcomes at Age 2 Years After Neonatal Hypoglycemia</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Edwards</surname>
                    <given-names>Taygen</given-names>
                  </name>
                  <degrees>MPopStud</degrees>
                  <xref rid="zoi221015aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Alsweiler</surname>
                    <given-names>Jane M.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi221015aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="zoi221015aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gamble</surname>
                    <given-names>Greg D.</given-names>
                  </name>
                  <degrees>MSc</degrees>
                  <xref rid="zoi221015aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Griffith</surname>
                    <given-names>Rebecca</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi221015aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lin</surname>
                    <given-names>Luling</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi221015aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>McKinlay</surname>
                    <given-names>Christopher J. D.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi221015aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="zoi221015aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rogers</surname>
                    <given-names>Jenny A.</given-names>
                  </name>
                  <degrees>MSc</degrees>
                  <xref rid="zoi221015aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Thompson</surname>
                    <given-names>Benjamin</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi221015aff5" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                  <xref rid="zoi221015aff6" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wouldes</surname>
                    <given-names>Trecia A.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi221015aff7" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Harding</surname>
                    <given-names>Jane E.</given-names>
                  </name>
                  <degrees>DPhil</degrees>
                  <xref rid="zoi221015aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="zoi221015aff1"><label>1</label>Liggins Institute, The University of Auckland, Auckland, New Zealand</aff>
              <aff id="zoi221015aff2"><label>2</label>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand</aff>
              <aff id="zoi221015aff3"><label>3</label>Newborn Services, Auckland City Hospital, Auckland, New Zealand</aff>
              <aff id="zoi221015aff4"><label>4</label>Kidz First Neonatal Care, Counties Manukau Health, Auckland, New Zealand</aff>
              <aff id="zoi221015aff5"><label>5</label>School of Optometry and Vision Science, Waterloo, Canada</aff>
              <aff id="zoi221015aff6"><label>6</label>Center for Eye and Vision Research, Hong Kong</aff>
              <aff id="zoi221015aff7"><label>7</label>Department of Psychological Medicine, The University of Auckland, Auckland, New Zealand</aff>
              <author-notes>
                <title>Article Information</title>
                <p><bold>Accepted for Publication:</bold> August 25, 2022.</p>
                <p content-type="published-online"><bold>Published:</bold> October 11, 2022. <?xpp bx;1?>doi:<uri content-type="doi">10.1001/jamanetworkopen.2022.35989</uri></p>
                <p content-type="open-access-note"><bold>Open Access:</bold> This is an open access article distributed under the terms of the <ext-link xlink:href="https://jamanetwork.com/pages/cc-by-license-permissions" ext-link-type="uri">CC-BY License</ext-link>. Â© 2022 Edwards T et al. <italic>JAMA Network Open</italic>.</p>
                <corresp id="zoi221015cor1"><bold>Corresponding Author:</bold> Jane E. Harding, DPhil, Liggins Institute, The University of Auckland, Private Bag 92019, Victoria St W, Auckland 1142, New Zealand (<email xlink:href="j.harding@auckland.ac.nz">j.harding@auckland.ac.nz</email>).</corresp>
                <p content-type="author-contributions"><bold>Author Contributions</bold>: Mr Gamble and Dr Harding had full access to all the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis.</p>
                <p><italic>Concept and design:</italic> Alsweiler, Gamble, McKinlay, Thompson, Wouldes, Harding.</p>
                <p><italic>Acquisition, analysis, or interpretation of data:</italic> Edwards, Gamble, Griffith, Lin, McKinlay, Rogers, Thompson, Wouldes, Harding.</p>
                <p><italic>Drafting of the manuscript:</italic> Edwards, Harding.</p>
                <p><italic>Critical revision of the manuscript for important intellectual content:</italic> All authors.</p>
                <p><italic>Statistical analysis:</italic> Edwards, Gamble, Lin, Wouldes, Harding.</p>
                <p><italic>Obtained funding:</italic> Alsweiler, Gamble, McKinlay, Thompson, Harding.</p>
                <p><italic>Administrative, technical, or material support:</italic> Edwards, Griffith, McKinlay, Rogers, Harding.</p>
                <p><italic>Supervision:</italic> McKinlay, Harding.</p>
                <p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> No disclosures were reported.</p>
                <p content-type="funding-statement"><bold>Funding/Support:</bold> This study was funded by grants from the Health Research Council of New Zealand (15/216) and the Eunice Kennedy Shriver National Institute of Child Health &amp; Human Development of the National Institutes of Health (R01HD091075).</p>
                <p><bold>Role of the Funder/Sponsor:</bold> The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p>
                <p><bold>Disclaimer:</bold> The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health &amp; Human Development or the National Institutes of Health.</p>
                <p><bold>Additional Contributions:</bold> Hypoglycaemia Prevention With Oral Dextrose Steering Group: Jane E Harding, DPhil (chair), Jane M. Alsweiler, PhD, Caroline Crowther, MD, Richard Edlin, PhD, Greg D. Gamble, MSc, Joanne E. Hegarty, PhD, Christopher J. D. McKinlay, PhD, Jenny A. Rogers, MSc, Benjamin Thompson, PhD, and Trecia A. Wouldes, PhD. hPOD study team (all affiliated with the Liggins Institute, The University of Auckland, Auckland, New Zealand): Alena Vasilenko, MD, Anna Mikaelian, MD, Anushika Kendaragama, MD, Grace McKnight, Heather Stewart, BSc, Jocelyn Ledger, Kate Kurkchi, MD, Kelly Fredell, BNurs, Nataliia Burakevych, PhD, Nina Slabkevich, MD, Olga Ivashkova, MD, Rashedul Hasan, MSc, Safayet Hossin, MSc, Rajesh Shah, PhD, Robin May, MD, and Sharin Asadi, PhD. All of the study team received compensation from The University of Auckland or the funders of the study. We thank the families who took part in this study.</p>
              </author-notes>
              <pub-date pub-type="epub" iso-8601-date="2022-10-11T10:00">
                <day>11</day>
                <month>10</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>10</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>11</day>
                <month>10</month>
                <year>2022</year>
              </pub-date>
              <!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.-->
              <volume>5</volume>
              <issue>10</issue>
              <elocation-id>e2235989</elocation-id>
              <history>
                <date date-type="received">
                  <day>17</day>
                  <month>5</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>25</day>
                  <month>8</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright 2022 Edwards T et al. <italic>JAMA Network Open</italic>.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the CC-BY License.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf-version" xlink:href="jamanetwopen-e2235989.pdf">jamanetwopen-e2235989.pdf</self-uri>
              <self-uri content-type="silverchair" xlink:href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.35989"/>
              <abstract abstract-type="key-points">
                <title>Key Points</title>
                <sec id="ab-zoi221015-1">
                  <title>Question</title>
                  <p>Is neonatal hypoglycemia associated with neurocognitive outcomes in otherwise well late preterm and full-term term neonates born at risk of hypoglycemia?</p>
                </sec>
                <sec id="ab-zoi221015-2">
                  <title>Findings</title>
                  <p>In this cohort study of 1197 participants in a randomized clinical trial, the prevalence of neurosensory impairment at 2 years was significantly higher in those who experienced hypoglycemia than in those who did not (23% vs 18%). The risk was greater in children who experienced severe episodes (28%).</p>
                </sec>
                <sec id="ab-zoi221015-3">
                  <title>Meaning</title>
                  <p>The findings of this study suggest that children who experienced neonatal hypoglycemia are at increased risk of neurosensory impairment at corrected age 2 years, even if screened and treated to maintain blood glucose concentrations greater than or equal to 47 mg/dL.</p>
                </sec>
              </abstract>
              <abstract>
                <sec id="ab-zoi221015-4">
                  <title>Importance</title>
                  <p>Neonatal hypoglycemia is common, but its association with later neurodevelopment is uncertain.</p>
                </sec>
                <sec id="ab-zoi221015-5">
                  <title>Objective</title>
                  <p>To examine associations between neonatal hypoglycemia and neurocognitive outcomes at corrected age 2 years.</p>
                </sec>
                <sec id="ab-zoi221015-6">
                  <title>Design, Setting, and Participants</title>
                  <p>Exploratory cohort analysis of the Hypoglycaemia Prevention With Oral Dextrose (hPOD) randomized clinical trial was conducted. The trial recruited participants from January 9, 2015, to May 5, 2019, with follow-up between January 26, 2017, and July 31, 2021. Infants were recruited from 9 maternity hospitals in New Zealand and assessed at home or in a research clinic. Children born late preterm and at term at risk of neonatal hypoglycemia but without evidence of acute or imminent illness in the first hour after birth were screened and treated to maintain blood glucose concentrations greater than or equal to 47 mg/dL.</p>
                </sec>
                <sec id="ab-zoi221015-7">
                  <title>Exposures</title>
                  <p>Hypoglycemia was defined as any blood glucose concentration less than 47 mg/dL, recurrent as 3 or more episodes, and severe as less than 36 mg/dL.</p>
                </sec>
                <sec id="ab-zoi221015-8">
                  <title>Main Outcomes and Measures</title>
                  <p>Neurologic examination and tests of development (Bayley III) and executive function. The primary outcome was neurosensory impairment (any of the following: blindness, deafness, cerebral palsy, developmental delay, or executive function total score worse than 1.5 SD below the mean).</p>
                </sec>
                <sec id="ab-zoi221015-9">
                  <title>Results</title>
                  <p>A total of 1197 of 1321 (91%) eligible children were assessed at a mean of corrected age 24 months; 616 (52%) were male. Compared with the normoglycemia group, children who experienced hypoglycemia were more likely to have neurosensory impairment (111 [23%] vs 125 [18%]; adjusted risk ratio [aRR], 1.28; 95% CI, 1.01-1.60), particularly if they experienced severe episodes (30 [28%] vs 125 [18%]; aRR, 1.68; 95% CI, 1.20-2.36), but not recurrent episodes (12 [19%] vs 125 [18%]; aRR, 1.06; 95% CI, 0.63-1.80). The risk of cognitive, language, or motor delay was similar between groups, but children who experienced hypoglycemia had lower Bayley-III composite cognitive (adjusted mean difference [aMD], â1.48; 95% CI, â2.79 to â0.18) and motor scores (aMD, â2.05; 95% CI, â3.30 to â0.79).</p>
                </sec>
                <sec id="ab-zoi221015-10">
                  <title>Conclusions and Relevance</title>
                  <p>In children born at risk of hypoglycemia but otherwise well, those who experienced neonatal hypoglycemia were more likely to have neurosensory impairment at corrected age 2 years, with higher risks after severe episodes. Further research is required to determine causality.</p>
                </sec>
              </abstract>
              <abstract abstract-type="teaser" specific-use="electronic">
                <p>This cohort study examines neurodevelopment in children at corrected age 2 years who experienced neonatal hypoglycemia.</p>
              </abstract>
            </article-meta>
          </front>
          <body>
            <sec id="H1-1-ZOI221015">
              <title>Introduction</title>
              <p>Neonatal hypoglycemia is common.<sup><xref rid="zoi221015r1" ref-type="bibr">1</xref>,<xref rid="zoi221015r2" ref-type="bibr">2</xref></sup> Symptomatic or prolonged hypoglycemia causes brain injury and death,<sup><xref rid="zoi221015r3" ref-type="bibr">3</xref>,<xref rid="zoi221015r4" ref-type="bibr">4</xref>,<xref rid="zoi221015r5" ref-type="bibr">5</xref></sup> but the outcomes associated with brief transitional hypoglycemia are less clear.<sup><xref rid="zoi221015r5" ref-type="bibr">5</xref></sup></p>
              <p>Neonatal hypoglycemia is associated with increased risk of preschool executive dysfunction and visual-motor impairment, but neurodevelopmental impairment has only been reported at ages 6 to 11 years,<sup><xref rid="zoi221015r6" ref-type="bibr">6</xref></sup> perhaps because the skills affected by hypoglycemia are best detected in older children.<sup><xref rid="zoi221015r7" ref-type="bibr">7</xref></sup> However, most studies were small or of poor quality and included neonates at risk of neonatal illnesses associated with both hypoglycemia and poorer neurodevelopmental outcomes, making it difficult to distinguish their separate effects.<sup><xref rid="zoi221015r5" ref-type="bibr">5</xref>,<xref rid="zoi221015r6" ref-type="bibr">6</xref>,<xref rid="zoi221015r8" ref-type="bibr">8</xref>,<xref rid="zoi221015r9" ref-type="bibr">9</xref></sup> We examined neonatal hypoglycemia and neurocognitive outcomes at corrected age 2 years in a large cohort of late preterm and full-term neonates born at risk of hypoglycemia but without evidence of acute neonatal illness.</p>
            </sec>
            <sec id="H1-2-ZOI221015">
              <title>Methods</title>
              <sec id="H2-1-ZOI221015">
                <title>Study Design and Participants</title>
                <p>This was an exploratory cohort analysis of the Hypoglycaemia Prevention With Oral Dextrose (hPOD) multicenter, randomized clinical trial and its 2-year follow-up, reported elsewhere.<sup><xref rid="zoi221015r10" ref-type="bibr">10</xref>,<xref rid="zoi221015r11" ref-type="bibr">11</xref>,<xref rid="zoi221015r12" ref-type="bibr">12</xref></sup> Eligible infants were recruited from 9 hospitals in New Zealand between January 9, 2015, and May 5, 2019. The primary outcome of the hPOD trial was admission to the neonatal intensive care unit (NICU) for 4 hours or longer<sup><xref rid="zoi221015r11" ref-type="bibr">11</xref></sup> and, of the follow-up study, was neurosensory impairment at corrected age 2 years.<sup><xref rid="zoi221015r12" ref-type="bibr">12</xref></sup> The hPOD trial registration number was <ext-link xlink:href="https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=367361" ext-link-type="uri">ACTRN12614001263684</ext-link>.</p>
              </sec>
              <sec id="H2-2-ZOI221015">
                <title>Inclusion Criteria</title>
                <p>Inclusion criteria were as follows: age less than 1 hour after birth, 1 or more risk factors for hypoglycemia (maternal diabetes, small [birthweight &lt;2.5 kg or &lt;10th centile], large [birthweight &gt;4.5 kg or &gt;90th centile], or preterm [35-36 weeksâ gestation]), birthweight greater than or equal to 2.2 kg, gestation greater than or equal to 35 weeks, no apparent indication for NICU admission, and mother intending to breastfeed.</p>
                <p>Eligible children of caregivers who provided written consent were assessed at corrected age 2 years between January 26, 2017, and July 31, 2021. Travel costs were reimbursed but no additional financial compensation was provided. The study was approved by the New Zealand Health and Disability Ethics Committee and follows the Strengthening the Reporting of Observational Studies in Epidemiology (<ext-link xlink:href="https://www.equator-network.org/reporting-guidelines/strobe/" ext-link-type="uri">STROBE</ext-link>) reporting guideline.</p>
              </sec>
              <sec id="H2-3-ZOI221015">
                <title>Procedures</title>
                <p>Neonates were randomized to prophylactic buccal dextrose, 40%, or placebo gel (0.5 mL/kg) 1 hour after birth and breastfed.<sup><xref rid="zoi221015r11" ref-type="bibr">11</xref></sup> Blood glucose concentration was measured using a glucose oxidase method 2 hours after birth, and neonates were then screened and treated for hypoglycemia according to hospital practice.<sup><xref rid="zoi221015r13" ref-type="bibr">13</xref></sup></p>
                <p>Hypoglycemia was defined as 1 or more episodes of consecutive blood glucose concentrations less than 47 mg/dL (to convert to millimoles per liter, multiply by 0.0555) in the first 48 hours after birth. Severity of hypoglycemia was defined as none (all blood glucose concentrations â¥47 mg/dL), mild (â¥1 episode â¥36 mg/dL and &lt;47 mg/dL), and severe (â¥1 episode &lt;36 mg/dL). Frequency of hypoglycemia was defined as none, 1 to 2 episodes, and recurrent as 3 or more episodes. Treatment for hypoglycemia usually involved combinations of supplemental feeds, buccal dextrose gel, and intravenous dextrose.</p>
                <p>At corrected age 2 years, children underwent neurologic examination and tests of development and executive function administered by trained assessors at a research clinic or at home. Caregivers completed questionnaires about the childâs medical and family history.</p>
                <p>Children were assessed using Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III) cognitive, language, and motor scales (mean [SD], 100 [15]) composite score.<sup><xref rid="zoi221015r14" ref-type="bibr">14</xref></sup> We assigned a score of 49 to children unable to be assessed due to severe delay. The performance-based executive function battery comprised 4 tasks measuring simple inhibition (snack delay task), complex inhibition (fruit Stroop and reverse categorization tasks), and attentional flexibility (multisearch/multilocation task).<sup><xref rid="zoi221015r15" ref-type="bibr">15</xref></sup> The scores of each task (range, 0-6 points; â¤2 indicates low performance) were summed to give an executive function total score (range, 0-24 points). For both assessments, higher scores indicate better performance.</p>
                <p>Socioeconomic status was reported using the New Zealand Deprivation Index 2018.<sup><xref rid="zoi221015r16" ref-type="bibr">16</xref></sup> Primary risk factor was prioritized in the following order: maternal diabetes, preterm, small, and large. Maternal ethnicity was self-reported and prioritized according to the New Zealand Standard Classification, as required by our ethics committee.<sup><xref rid="zoi221015r17" ref-type="bibr">17</xref></sup></p>
              </sec>
              <sec id="H2-4-ZOI221015">
                <title>Outcomes</title>
                <p>The primary outcome was neurosensory impairment, defined as any of the following: blindness (visual acuity &lt;3/60 or &gt;1.3 logMAR), hearing impairment requiring aids, cerebral palsy, developmental delay (Bayley-III cognitive, language, or motor composite score &lt;85), or performance-based executive function total score more than 1.5 SD below the cohort mean.</p>
                <p>Secondary outcomes were components of the primary outcome and severity. Moderate or severe neurosensory impairment was defined as any of the following: blindness, hearing impairment requiring aids, moderate or severe cerebral palsy (not walking yet or permanently nonambulant), or moderate or severe developmental delay. Developmental delay was defined as none (Bayley-III cognitive, language, and motor composite score â¥85), mild (Bayley-III cognitive, language, or motor composite score, 70-84), and moderate or severe (Bayley-III cognitive, language, or motor composite score &lt;70).</p>
              </sec>
              <sec id="H2-5-ZOI221015">
                <title>Statistical Analysis</title>
                <p>Analyses were prespecified, unless otherwise indicated. We imputed scores of children missing 1 or more task scores on the performance-based executive function battery, using the cohort mode to calculate an executive function total score. We did not impute other data because it was assumed missing not at random. We did not adjust for multiplicity because this study was exploratory. We compared categorical data using Fisher exact or Ï<sup>2</sup> tests and continuous data using independent-sample <italic>t</italic> tests or Wilcoxon rank sum tests.</p>
                <p>For primary analyses, we compared the risk of the primary and categorical secondary outcomes between children who experienced 1 or more episodes of hypoglycemia (hypoglycemia group) and children with no episodes (normoglycemia group) using log-binomial generalized linear regression adjusted for hospital site, socioeconomic decile,<sup><xref rid="zoi221015r17" ref-type="bibr">17</xref></sup> primary reason for risk of hypoglycemia, and multiple births as fixed effects. We compared secondary continuous outcomes using identity-normal generalized linear regression and ordinal outcomes using generalized cumulative logit regression. We compared none vs mild and none vs severe for severity outcomes using log-binomial generalized linear regression.</p>
                <p>For secondary analyses, we compared no episodes of hypoglycemia with mild or severe episodes and 1 or 2 or recurrent episodes, using the same methods as the primary analysis. In a post hoc analysis restricted to children who experienced hypoglycemia, we tested for interactions between frequency of episodes and treatment (buccal dextrose plus feed vs intravenous dextrose) on the risk of neurosensory impairment, moderate, or severe neurosensory impairment, and their components, using adjusted generalized linear modeling.</p>
                <p>In subgroup analyses, we compared neurosensory impairment, moderate or severe neurosensory impairment, and their components between children of mothers with diabetes and those with other risk factors for hypoglycemia, and between boys and girls using adjusted generalized linear regression with interaction terms. In sensitivity analyses, we excluded children with postneonatal diagnoses likely to affect the outcome, whose first language was not English, and assessed outside the planned assessment window of corrected ages 23 to 25 months. Because this cohort participated in a randomized trial, we undertook a sensitivity analysis of the primary outcome excluding children randomized to the intervention (prophylactic buccal dextrose gel).</p>
                <p>We performed all analyses in SAS, version 9.4 (SAS Institute Inc) using 2-sided tests with 95% CIs and <italic>P</italic>ââ¤â.05 considered statistically significant. Data are presented as unadjusted risk difference or mean difference (MD), and adjusted risk ratio (aRR) or mean difference (aMD), with 95% CIs.</p>
              </sec>
            </sec>
            <sec id="H1-3-ZOI221015">
              <title>Results</title>
              <p>There were 1359 children recruited to the hPOD Trial in New Zealand; 35 families declined consent for future contact and 3 infants died after the neonatal period, leaving 1321 children eligible for follow-up (<xref rid="zoi221015f1" ref-type="fig">Figure</xref>). Of these, 1197 (91%) were assessed at 2 years. Three children were excluded because blood glucose concentration data were unavailable, leaving 1194 children in the analysis: 704 (59%) in the normoglycemia group and 490 (41%) in the hypoglycemia group (383 [78%] mild, 107 [22%] severe, 427 [87%] 1-2 episodes, and 63 [13%] recurrent episodes). Six hundred seven children (51%) had been randomized to prophylactic buccal dextrose gel and 587 (49%) to placebo gel.</p>
              <fig position="float" id="zoi221015f1" fig-type="figure">
                <label>Figure. </label>
                <caption>
                  <title>Study Flow</title>
                  <p>Three of the 1197 children assessed who did not have blood glucose concentration data were excluded from the final analysis. Bayley-III indicates Bayley Scales of Infant and Toddler Development, Third Edition; hPOD, Hypoglycaemia Prevention With Oral Dextrose Trial.</p>
                </caption>
                <graphic xlink:href="jamanetwopen-e2235989-g001" position="float"/>
              </fig>
              <p>Children were assessed at a mean (SD) corrected age of 24 (1.4) months; 578 (48%) were female and 616 (52%) were male. Maternal and child characteristics were similar between those assessed and not assessed, except more children of European mothers were assessed (eTable 1 in the <xref rid="note-ZOI221015-1-s" ref-type="supplementary-material">Supplement</xref>). Among those assessed, children who became hypoglycemic were more likely to be male (270 [55%] vs 346 [49%]), have a lower gestational age (mean [SD], 37.8 [1.2] vs 38.2 [1.1] weeks) and birthweight (mean [SD], 3241 [639.3] vs 3403 [645.9] g), be a twin (51 [10%] vs 44 [6%]) or born preterm (63 [13%] vs 39 [6%]), admitted to NICU (75 [15%] vs 19 [3%]), and randomized to placebo gel (258 [43%] vs 229 [38%]) (<xref rid="zoi221015t1" ref-type="table">Table 1</xref>). Primary outcome data were available for 1191 children: 487 in the hypoglycemia group and 704 in the normoglycemia group.</p>
              <table-wrap position="float" id="zoi221015t1">
                <label>Table 1. </label>
                <caption>
                  <title>Maternal and Neonatal Characteristics</title>
                </caption>
                <table frame="hsides" rules="groups">
                  <col width="44.43%" span="1"/>
                  <col width="20.01%" span="1"/>
                  <col width="17.78%" span="1"/>
                  <col width="17.78%" span="1"/>
                  <thead>
                    <tr>
                      <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Variable</th>
                      <th colspan="3" valign="top" align="left" scope="colgroup" rowspan="1">No. (%)</th>
                    </tr>
                    <tr>
                      <th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Total</th>
                      <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Hypoglycemia group</th>
                      <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Normoglycemia group</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td colspan="4" valign="top" align="left" scope="col" rowspan="1">
                        <bold>Mothers<xref rid="zoi221015t1n1" ref-type="table-fn"><sup>a</sup></xref></bold>
                      </td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Total No.</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">1180</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">484</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">696</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age, mean (SD), y<xref rid="zoi221015t1n2" ref-type="table-fn"><sup>b</sup></xref></td>
                      <td valign="top" align="left" rowspan="1" colspan="1">32.4 (5.3)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">32.4 (5.3)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">32.3 (5.3)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Prioritized ethnicity<xref rid="zoi221015t1n3" ref-type="table-fn"><sup>c</sup></xref></td>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Total No.</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">1179</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">484</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">695</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> MÄori</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">213 (18.1)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">74 (15.3)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">139 (20.0)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Pacific</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">103 (8.7)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">50 (10.3)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">53 (7.6)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Asian</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">187 (15.9)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">73 (15.1)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">114 (16.4)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Indian</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">156 (13.2)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">61 (12.6)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">95 (13.7)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">61 (5.2)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">24 (5.0)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">37 (5.3)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> European</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">459 (38.9)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">202 (41.7)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">257 (37.0)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cesarean delivery</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">507 (43.0)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">218 (45.0)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">289 (41.5)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Diabetes</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">903 (76.5)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">356 (73.6)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">547 (78.6)</td>
                    </tr>
                    <tr>
                      <td colspan="4" valign="top" align="left" scope="col" rowspan="1">
                        <bold>Infants</bold>
                      </td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Total No.</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">1194</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">490</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">704</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Randomized to buccal dextrose gel</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">607 (50.8)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">232 (47.3)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">375 (53.3)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Female</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">578 (48.4)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">220 (44.9)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">358 (50.9)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Male</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">616 (51.6)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">270 (55.1)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">346 (49.1)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Gestation, mean (SD), wk<xref rid="zoi221015t1n4" ref-type="table-fn"><sup>d</sup></xref></td>
                      <td valign="top" align="left" rowspan="1" colspan="1">38.0 (1.2)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">37.8 (1.2)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">38.2 (1.1)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Birthweight, mean (SD), g<xref rid="zoi221015t1n4" ref-type="table-fn"><sup>d</sup></xref></td>
                      <td valign="top" align="left" rowspan="1" colspan="1">3337 (647.8)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">3241 (639.3)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">3403 (645.9)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Birthweight <italic>z</italic> score, mean (SD)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">0.28 (1.2)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">0.17 (1.2)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">0.36 (1.2)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">One of twins</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">95 (8.0)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">51 (10.4)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">44 (6.3)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Socioeconomic decile<xref rid="zoi221015t1n5" ref-type="table-fn"><sup>e</sup></xref></td>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> No.</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">1189</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">487</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">702</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 1-2 (Least deprived)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">179 (15.0)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">70 (14.4)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">109 (15.5)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 3-4</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">228 (19.2)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">90 (18.5)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">138 (19.7)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 5-6</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">252 (21.2)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">114 (23.4)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">138 (19.7)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 7-8</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">279 (23.5)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">117 (24.0)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">162 (23.1)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 9-10 (Most deprived)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">251 (21.1)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">96 (19.7)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">155 (22.1)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Primary risk factor<xref rid="zoi221015t1n6" ref-type="table-fn"><sup>f</sup></xref></td>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mother with diabetes</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">901 (75.5)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">352 (71.8)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">549 (78.0)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Preterm</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">102 (8.5)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">63 (12.9)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">39 (5.5)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Small</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">122 (10.2)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">53 (10.8)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">69 (9.8)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Large</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">69 (5.8)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">22 (4.5)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">47 (6.7)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">First blood glucose concentration, mean (SD), mg/dL<xref rid="zoi221015t1n7" ref-type="table-fn"><sup>g</sup></xref></td>
                      <td valign="top" align="left" rowspan="1" colspan="1">55.8 (13.2)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">47.8 (12.7)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">61.4 (10.3)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hypoglycemia<xref rid="zoi221015t1n8" ref-type="table-fn"><sup>h</sup></xref></td>
                      <td valign="top" align="left" rowspan="1" colspan="1">490 (41.0)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">490 (100.0)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">0</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild<xref rid="zoi221015t1n9" ref-type="table-fn"><sup>i</sup></xref></td>
                      <td valign="top" align="left" rowspan="1" colspan="1">383 (32.1)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">383 (78.2)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">0</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Severe<xref rid="zoi221015t1n10" ref-type="table-fn"><sup>j</sup></xref></td>
                      <td valign="top" align="left" rowspan="1" colspan="1">107 (9.0)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">107 (21.8)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">0</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 1-2 Episodes</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">427 (35.8)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">427 (87.1)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">0</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Recurrent<xref rid="zoi221015t1n11" ref-type="table-fn"><sup>k</sup></xref></td>
                      <td valign="top" align="left" rowspan="1" colspan="1">63 (5.3)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">63 (12.9)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">0</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Treatment for hypoglycemia</td>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Buccal dextrose plus feed only</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">420 (35.2)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">420 (85.7)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">0</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Intravenous dextrose</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">36 (3.0)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">36 (7.3)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">0</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Admission to NICU</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">94 (7.9)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">75 (15.3)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">19 (2.7)</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <p>Abbreviation: NICU, neonatal intensive care unit.</p>
                  <p>SI conversion factor: To convert blood glucose to mmol/L, multiply by 0.0555.</p>
                  <fn id="zoi221015t1n1">
                    <label>
                      <sup>a</sup>
                    </label>
                    <p>Mothers included once per pregnancy because some mothers had 1 or more pregnancy and child in this cohort.</p>
                  </fn>
                  <fn id="zoi221015t1n2">
                    <label>
                      <sup>b</sup>
                    </label>
                    <p>Missing data for 2 mothers (1 hypoglycemia, 1 normoglycemia).</p>
                  </fn>
                  <fn id="zoi221015t1n3">
                    <label>
                      <sup>c</sup>
                    </label>
                    <p>Self-reported maternal ethnicity was prioritized using the New Zealand Ministry of Health classifications. Other included African, Canadian/Brazilian, Colombian, Fijian, Hawaiian, Indonesian, Kurdish, Latin American, Lebanese, Malaysian, Malaysian Indian, Mauritian, Middle Eastern, Nepalese, Somali, South African, and unspecified.</p>
                  </fn>
                  <fn id="zoi221015t1n4">
                    <label>
                      <sup>d</sup>
                    </label>
                    <p>Missing data for 1 infant (normoglycemia).</p>
                  </fn>
                  <fn id="zoi221015t1n5">
                    <label>
                      <sup>e</sup>
                    </label>
                    <p>New Zealand Socioeconomic Deprivation Index.</p>
                  </fn>
                  <fn id="zoi221015t1n6">
                    <label>
                      <sup>f</sup>
                    </label>
                    <p>Primary risk factor was reported according to priority.</p>
                  </fn>
                  <fn id="zoi221015t1n7">
                    <label>
                      <sup>g</sup>
                    </label>
                    <p>Missing data for 3 infants (normoglycemia).</p>
                  </fn>
                  <fn id="zoi221015t1n8">
                    <label>
                      <sup>h</sup>
                    </label>
                    <p>Defined as 1 or more episodes of consecutive blood glucose concentrations less than 47 mg/dL.</p>
                  </fn>
                  <fn id="zoi221015t1n9">
                    <label>
                      <sup>i</sup>
                    </label>
                    <p>Defined as 1 or more episodes of greater than or equal to 36 mg/dL and less than 47 mg/dL.</p>
                  </fn>
                  <fn id="zoi221015t1n10">
                    <label>
                      <sup>j</sup>
                    </label>
                    <p>Defined as 1 or more episodes of less than 36 mg/dL.</p>
                  </fn>
                  <fn id="zoi221015t1n11">
                    <label>
                      <sup>k</sup>
                    </label>
                    <p>Defined as 3 or more episodes.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <sec id="H2-6-ZOI221015">
                <title>Primary Analyses</title>
                <p>Compared with the normoglycemia group, children who experienced hypoglycemia were more likely to have neurosensory impairment (23% [111 of 487] vs 18% [125 of 704]; aRR, 1.28; 95% CI, 1.01-1.60) (<xref rid="zoi221015t2" ref-type="table">Table 2</xref>). The risks of cognitive, language, or motor delay were similar between groups, but children who experienced hypoglycemia had lower Bayley-III cognitive (mean [SD], 97.8 [11.2] vs 99.0 [11.2]; aMD, â1.48 [95% CI, â2.79 to â0.18]) and motor (103.0 [10.3] vs 104.8 [10.8]; aMD, â2.05 [95% CI, â3.30 to â0.79]) composite scores (<xref rid="zoi221015t2" ref-type="table">Table 2</xref>). There were no significant differences between groups in the risk of moderate or severe neurosensory impairment, cerebral palsy, developmental delay, Bayley-III language composite score, and executive function (<xref rid="zoi221015t2" ref-type="table">Table 2</xref>; eTable 2 in the <xref rid="note-ZOI221015-1-s" ref-type="supplementary-material">Supplement</xref>). In the hypoglycemia group, 2 children were blind and 3 had hearing impairment.</p>
                <table-wrap position="float" id="zoi221015t2">
                  <label>Table 2. </label>
                  <caption>
                    <title>Associations Between Neonatal Hypoglycemia and Neurosensory Impairment at Corrected Age 2 Years<xref rid="zoi221015t2n1" ref-type="table-fn"><sup>a</sup></xref></title>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col width="16.8%" span="1"/>
                    <col width="17.6%" span="1"/>
                    <col width="20%" span="1"/>
                    <col width="18.4%" span="1"/>
                    <col width="18.4%" span="1"/>
                    <col width="8.8%" span="1"/>
                    <thead>
                      <tr>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Primary outcome</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">No./total No. (%)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">RD/MD (95% CI)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">RR (95% CI)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Adjusted RR/MD (95% CI)<xref rid="zoi221015t2n2" ref-type="table-fn"><sup>b</sup></xref></th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic>P</italic> value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Normoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">125/704 (17.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hypoglycemia<xref rid="zoi221015t2n3" ref-type="table-fn"><sup>c</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">111/487 (22.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">5.04 (0.36 to 9.72)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.28 (1.02 to 1.61)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.28 (1.01 to 1.60)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.04</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Severity of hypoglycemia<xref rid="zoi221015t2n4" ref-type="table-fn"><sup>d</sup></xref><sup>,</sup><xref rid="zoi221015t2n5" ref-type="table-fn"><sup>e</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1">.02</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">81/381 (21.3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3.50 (â1.49 to 8.49)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.20 (0.93 to 1.54)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.18 (0.92 to 1.52)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.19</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Severe</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">30/106 (28.3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10.55 (1.51 to 19.59)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.59 (1.13 to 2.25)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.68 (1.20 to 2.36)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.003</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Frequency of hypoglycemia <xref rid="zoi221015t2n6" ref-type="table-fn"><sup>f</sup></xref><sup>,</sup><xref rid="zoi221015t2n7" ref-type="table-fn"><sup>g</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1">.08</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 1-2 episodes</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">99/424 (23.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">5.59 (0.67 to 10.52)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.32 (1.04 to 1.66)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.29 (1.02 to 1.64)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.03</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Recurrent</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">12/63 (19.1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.29 (â8.82 to 11.41)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.07 (0.63 to 1.83)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.06 (0.63 to 1.80)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.83</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <p>Abbreviations: MD, mean difference; RD, risk difference; RR, risk ratio.</p>
                    <fn id="zoi221015t2n1">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Defined as any of the following: blindness (visual acuity &lt;3/60 or &gt;1.3 logMAR), hearing impairment requiring aids, cerebral palsy, developmental delay (Bayley-III cognitive, language, or motor composite score &lt;85), or performance-based executive function total score more than 1.5 SD below the cohort mean.</p>
                    </fn>
                    <fn id="zoi221015t2n2">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>Adjusted for study site, primary reason for risk of hypoglycemia, socioeconomic decile at birth, and multiple births.</p>
                    </fn>
                    <fn id="zoi221015t2n3">
                      <label>
                        <sup>c</sup>
                      </label>
                      <p>An episode of hypoglycemia was defined as 1 or more episode of consecutive blood glucose concentrations less than 47 mg/dL (to convert glucose to millimoles per liter, multiply by 0.0555).</p>
                    </fn>
                    <fn id="zoi221015t2n4">
                      <label>
                        <sup>d</sup>
                      </label>
                      <p>The severity of hypoglycemia was defined as none (all blood glucose concentrations â¥47 mg/dL), mild (â¥1 episode of â¥36 and &lt;47 mg/dL), and severe (â¥1 episode of &lt;36 mg/dL).</p>
                    </fn>
                    <fn id="zoi221015t2n5">
                      <label>
                        <sup>e</sup>
                      </label>
                      <p><italic>P</italic> values reported for the overall association between severity of hypoglycemia and outcome, none vs mild, and none vs severe.</p>
                    </fn>
                    <fn id="zoi221015t2n6">
                      <label>
                        <sup>f</sup>
                      </label>
                      <p>The frequency of hypoglycemia was defined as none (all blood glucose concentrations â¥47 mg/dL), 1 to 2 episodes of consecutive blood glucose concentrations less than 47 mg/dL, and recurrent (â¥3 episodes of consecutive blood glucose concentrations &lt;47 mg/dL).</p>
                    </fn>
                    <fn id="zoi221015t2n7">
                      <label>
                        <sup>g</sup>
                      </label>
                      <p><italic>P</italic> values reported for the overall association between frequency of hypoglycemia and outcome, none vs 1 to 2 episodes, and none vs recurrent (ie, â¥3 episodes of consecutive blood glucose concentrations &lt;47 mg/dL).</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="H2-7-ZOI221015">
                <title>Secondary Analyses</title>
                <p>Compared with the normoglycemia group, children who experienced severe hypoglycemia had a higher risk of neurosensory impairment (28% [30 of 106] vs 18% [125 of 704]; aRR, 1.68 [95% CI, 1.20-2.36]). They also had a higher risk of developmental delay (24% [25 of 106] vs 16% [114 of 701]; aRR, 1.54 [95% CI, 1.05 to 2.26]), language delay (23% [24 of 106] vs 15% [104 of 702]; aRR, 1.65 [95% CI, 1.11 to 2.45]), motor delay (4% [4 of 106] vs 1% [10 of 702]; aRR, 3.40 [95% CI, 1.03 to 11.21]), and low performance on the snack delay task (85% [90 of 106] vs 73% [513 of 701]; aRR, 1.11 [95% CI, 1.01 to 1.22]) (<xref rid="zoi221015t3" ref-type="table">Table 3</xref>; eTable 2 in the <xref rid="note-ZOI221015-1-s" ref-type="supplementary-material">Supplement</xref>).</p>
                <table-wrap position="float" id="zoi221015t3">
                  <label>Table 3. </label>
                  <caption>
                    <title>Associations Between Neonatal Hypoglycemia and Neurocognitive Outcomes at Corrected Age 2 Years</title>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col width="17.06%" span="1"/>
                    <col width="14.93%" span="1"/>
                    <col width="14.21%" span="1"/>
                    <col width="17.06%" span="1"/>
                    <col width="15.13%" span="1"/>
                    <col width="15.41%" span="1"/>
                    <col width="6.2%" span="1"/>
                    <thead>
                      <tr>
                        <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Secondary outcome</th>
                        <th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">No./total No. (%)</th>
                        <th rowspan="2" valign="top" align="left" scope="col" colspan="1">RD/MD (95% CI)</th>
                        <th rowspan="2" valign="top" align="left" scope="col" colspan="1">RR (95% CI)</th>
                        <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Adjusted RR/MD (95% CI)<xref rid="zoi221015t3n1" ref-type="table-fn"><sup>a</sup></xref></th>
                        <th rowspan="2" valign="top" align="left" scope="col" colspan="1"><italic>P</italic> value<xref rid="zoi221015t3n2" ref-type="table-fn"><sup>b</sup></xref></th>
                      </tr>
                      <tr>
                        <th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Hypoglycemia group (nâ=â490)<xref rid="zoi221015t3n3" ref-type="table-fn"><sup>c</sup></xref></th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Normoglycemia group (nâ=â704)<xref rid="zoi221015t3n3" ref-type="table-fn"><sup>c</sup></xref></th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Moderate or severe neurosensory impairment<xref rid="zoi221015t3n4" ref-type="table-fn"><sup>d</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">20/487 (4.1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">20/704 (2.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.27 (â0.88 to 3.42)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.45 (0.79 to 2.66)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.41 (0.76 to 2.62)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.28</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cerebral palsy</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2/481 (0.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1/700 (0.1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.27 (â0.37 to 0.91)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NC</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NC</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">479/481 (99.6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">699/700 (99.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â0.27 (â0.91 to 0.37)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0/481</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1/700 (0.1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â0.14 (NE)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NE</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NE</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Moderate or severe</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2/481 (0.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0/700</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.42 (NE)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NE</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NE</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Developmental delay<xref rid="zoi221015t3n5" ref-type="table-fn"><sup>e</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">94/483 (19.5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">114/701 (16.3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3.20 (â1.27 to 7.67)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.20 (0.93 to 1.53)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.18 (0.92 to 1.51)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.19</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">389/483 (80.5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">587/701 (83.7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â3.20 (â7.67 to 1.27)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="middle" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">79/483 (16.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">94/701 (13.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2.95 (â1.21 to 7.10)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.22 (0.93 to 1.61)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.21 (0.92 to 1.59)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.18</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Moderate or severe</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">15/483 (3.1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">20/701 (2.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.25 (â1.73 to 2.23)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.13 (0.58 to 2.18)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.11 (0.57 to 2.17)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.76</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cognitive delay<xref rid="zoi221015t3n5" ref-type="table-fn"><sup>e</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">35/486 (7.2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">42/703 (6.0)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.16 (â1.72 to 4.03)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.21 (0.78 to 1.86)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.22 (0.79 to 1.89)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.37</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">451/486 (92.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">661/703 (94.0)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â1.23 (â4.12 to 1.67)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="middle" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">31/486 (6.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">36/703 (5.1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.26 (â1.46 to 3.98)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.25 (0.78 to 1.99)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.28 (0.80 to 2.06)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.30</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Moderate or severe</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4/486 (0.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6/703 (0.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â0.03 (â1.08 to 1.02)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.98 (0.28 to 3.45)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.82 (0.23 to 2.85)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.76</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Language delay<xref rid="zoi221015t3n5" ref-type="table-fn"><sup>e</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">85/486 (17.5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">104/702 (14.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2.68 (â1.61 to 6.96)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.18 (0.91 to 1.53)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.16 (0.89 to 1.52)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.26</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">401/486 (82.5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">598/702 (85.2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â2.68 (â6.96 to 1.61)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="middle" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">71/486 (14.6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">87/702 (12.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2.22 (â1.76 to 6.20)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.18 (0.89 to 1.58)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.17 (0.87 to 1.57)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.29</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Moderate or severe</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14/486 (2.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">17/702 (2.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.46 (â1.42 to 2.33)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.22 (0.61 to 2.45)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.18 (0.58 to 2.40)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.64</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Motor delay<xref rid="zoi221015t3n5" ref-type="table-fn"><sup>e</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">9/483 (1.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10/702 (1.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.44 (â1.05 to 1.93)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.31 (0.54 to 3.20)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.38 (0.56 to 3.42)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.48</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">474/483 (98.1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">692/702 (98.6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â0.44 (â1.93 to 1.05)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="middle" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8/483 (1.7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">7/702 (1.0)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.66 (â0.70 to 2.02)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.66 (0.60 to 4.54)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.77 (0.63 to 4.96)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.28</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Moderate or severe</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1/483 (0.2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3/702 (0.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â0.22 (â0.85 to 0.41)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.49 (0.05 to 4.69)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.53 (0.05 to 5.20)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.58</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Bayley-III total scores, mean (SD) [total No.]<xref rid="zoi221015t3n5" ref-type="table-fn"><sup>e</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Cognitive score</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">97.8 (11.2) [486]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">99.0 (11.2) [703]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â1.20 (â2.50 to 0.10)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â1.48 (â2.79 to â0.18)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.03</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Language score</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">98.3 (15.8) [486]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">98.6 (15.0) [702]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â0.33 (â2.11 to 1.44)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â0.51 (â2.29 to 1.28)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.58</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Motor score</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">103.0 (10.3) [483]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">104.8 (10.8) [702]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â1.82 (â3.05 to â0.59)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â2.05 (â3.30 to â0.79)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.001</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Poor executive function<xref rid="zoi221015t3n6" ref-type="table-fn"><sup>f</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">33/483 (6.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">36/701 (5.1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.70 (â1.09 to 4.48)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.33 (0.84 to 2.10)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.31 (0.82 to 2.10)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.25</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Executive function total score, mean (SD) [total No.]<xref rid="zoi221015t3n7" ref-type="table-fn"><sup>g</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10.3 (4.5) [483]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10.6 (4.4) [701]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â0.30 (â0.82 to 0.22)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â0.19 (â0.70 to 0.33)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.48</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <p>Abbreviations: Bayley-III, Bayley Scales of Infant and Toddler Development, Third Edition; MD, mean difference; NA, not applicable; NC, not calculated owing to small numbers; NE, not estimable; RD, risk difference; RR, risk ratio.</p>
                    <fn id="zoi221015t3n1">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Adjusted for study site, primary reason for risk of hypoglycemia, socioeconomic decile at birth, and multiple births.</p>
                    </fn>
                    <fn id="zoi221015t3n2">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>First <italic>P</italic> value reported in the outcome row is for the overall association between severity of hypoglycemia and outcome. The <italic>P</italic> values below in mild and severe rows are for the comparison between none vs mild or none vs severe.</p>
                    </fn>
                    <fn id="zoi221015t3n3">
                      <label>
                        <sup>c</sup>
                      </label>
                      <p>An episode of hypoglycemia was defined as 1 or more episodes of consecutive blood glucose concentrations less than 47 mg/dL (to convert glucose to millimoles per liter, multiply by 0.0555).</p>
                    </fn>
                    <fn id="zoi221015t3n4">
                      <label>
                        <sup>d</sup>
                      </label>
                      <p>Defined as any of the following: blindness, hearing impairment requiring aids, moderate or severe cerebral palsy (not walking yet or permanently nonambulant), or moderate or severe developmental delay.</p>
                    </fn>
                    <fn id="zoi221015t3n5">
                      <label>
                        <sup>e</sup>
                      </label>
                      <p>One child in the hypoglycemia group was assigned a score of 49 for the Bayley-III cognitive, language, and motor scales because the child was unable to finish the assessment due to severe delay. Language, cognitive, and motor scales, mean (100), SD (15), and higher scores indicate better performance.</p>
                    </fn>
                    <fn id="zoi221015t3n6">
                      <label>
                        <sup>f</sup>
                      </label>
                      <p>Defined as an executive function total score more than 1.5 SD below the mean.</p>
                    </fn>
                    <fn id="zoi221015t3n7">
                      <label>
                        <sup>g</sup>
                      </label>
                      <p>Total score range 0 to 24 points; higher scores indicate better performance. eTable 2 in the <xref rid="note-ZOI221015-1-s" ref-type="supplementary-material">Supplement</xref> presents the executive function component results.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Compared with Bayley-III motor composite scores in the normoglycemia group (mean [SD], 104.8 [10.8]), scores were lower in children who experienced mild (103.3 [9.9]; aMD, â1.69 [95% CI, â3.04 to â0.34]) and severe episodes (101.8 [11.3]; aMD, â3.39 [95% CI, â5.67 to â1.11]) (overall <italic>P</italic>â=â.003) (<xref rid="zoi221015t4" ref-type="table">Table 4</xref>). Severity of hypoglycemia was not associated with moderate or severe neurosensory impairment, cerebral palsy, cognitive delay, or composite cognitive or language scores.</p>
                <table-wrap position="float" id="zoi221015t4">
                  <label>Table 4. </label>
                  <caption>
                    <title>Associations Between Severity of Neonatal Hypoglycemia and Neurocognitive Outcomes at Corrected Age 2 Years<xref rid="zoi221015t4n1" ref-type="table-fn"><sup>a</sup></xref></title>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col width="33.17%" span="1"/>
                    <col width="12.24%" span="1"/>
                    <col width="14.89%" span="1"/>
                    <col width="13.87%" span="1"/>
                    <col width="19.35%" span="1"/>
                    <col width="6.48%" span="1"/>
                    <thead>
                      <tr>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Variable</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">No./total (%)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">RD/MD (95% CI)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">RR (95% CI)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Adjusted RR/MD (95% CI)<xref rid="zoi221015t4n2" ref-type="table-fn"><sup>b</sup></xref></th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic>P</italic> value<xref rid="zoi221015t4n3" ref-type="table-fn"><sup>c</sup></xref></th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Moderate or severe neurosensory impairment<xref rid="zoi221015t4n4" ref-type="table-fn"><sup>d</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1">.55</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">20/704 (2.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">16/381 (4.2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.36 (â1.00 to 3.72)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.48 (0.77 to 2.82)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.42 (0.74 to 2.75)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.29</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Severe hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4/106 (3.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.93 (â2.90 to 4.77)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.33 (0.46 to 3.82)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.51 (0.51 to 4.52)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.46</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cerebral palsy</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1">.41</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1/700 (0.1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1/377 (0.3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.12 (â0.47 to 0.71)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.86 (0.12 to 29.69)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NC</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Severe hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1/104 (1.0)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.82 (â1.08 to 2.72)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6.73 (0.42 to 107.23)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NC</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Developmental delay<xref rid="zoi221015t4n5" ref-type="table-fn"><sup>e</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1">.11</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">114/701 (16.3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">69/377 (18.3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2.04 (â2.73 to 6.81)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.13 (0.86 to 1.48)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.10 (0.83 to 1.45)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.51</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Severe hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">25/106 (23.6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">7.32 (â1.22 to 15.87)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.45 (0.99 to 2.13)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.54 (1.05 to 2.26)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.03</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cognitive delay<xref rid="zoi221015t4n5" ref-type="table-fn"><sup>e</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1">.24</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">42/703 (6.0)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">24/380 (6.3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.34 (â2.67 to 3.35)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.06 (0.65 to 1.72)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.07 (0.65 to 1.75)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.80</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Severe hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">11/106 (10.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4.40 (â1.67 to 10.48)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.74 (0.92 to 3.27)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.78 (0.94 to 3.37)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.08</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Language delay<xref rid="zoi221015t4n5" ref-type="table-fn"><sup>e</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1">.05</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">104/702 (14.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">61/380 (16.1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.24 (â3.30 to 5.77)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.08 (0.81 to 1.45)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.06 (0.79 to 1.42)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.72</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Severe hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">24/106 (22.6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">7.83 (â0.58 to 16.23)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.53 (1.03 to 2.27)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.65 (1.11 to 2.45)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.01</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Motor delay<xref rid="zoi221015t4n5" ref-type="table-fn"><sup>e</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1">.13</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10/702 (1.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">5/377 (1.3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â0.10 (â1.55 to 1.35)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.93 (0.32 to 2.71)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.02 (0.34 to 3.04)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.98</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Severe hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4/106 (3.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2.35 (â1.39 to 6.09)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2.65 (0.84 to 8.31)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3.40 (1.03 to 11.21)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.04</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bayley-III cognitive score, mean (SD) [total]<xref rid="zoi221015t4n5" ref-type="table-fn"><sup>e</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1">.08</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">99.0 (11.2) [703]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">97.9 (10.7) [380]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â1.11 (â2.51 to 0.30)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â1.39 (â2.79 to â0.00)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.05</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Severe hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">97.5 (12.8) [106]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â1.54 (â3.84 to 0.76)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â1.62 (â3.97 to 0.73)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.18</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bayley-III language score, mean (SD) [total]<xref rid="zoi221015t4n5" ref-type="table-fn"><sup>e</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1">.49</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">98.6 (15.0) [702]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">98.6 (15.8) [380]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â0.02 (â1.94 to 1.90)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â0.13 (â2.05 to 1.79)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.90</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Severe hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">97.2 (15.7) [106]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â1.45 (â4.59 to 1.68)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â2.06 (â5.17 to 1.04)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.19</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bayley-III motor score, mean (SD) [total No.]<xref rid="zoi221015t4n5" ref-type="table-fn"><sup>e</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1">.003</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">104.8 (10.8) [702]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">103.3 (9.9) [377]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â1.49 (â2.81 to â0.16)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â1.69 (â3.04 to â0.34)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.01</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Severe hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">101.8 (11.3) [106]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â3.00 (â5.16 to â0.84)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â3.39 (â5.67 to â1.11)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.004</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Poor executive function<xref rid="zoi221015t4n6" ref-type="table-fn"><sup>f</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1">.41</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">36/701 (5.1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">24/377 (6.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.23 (â1.73 to 4.19)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.24 (0.75 to 2.05)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.24 (0.74 to 2.06)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.42</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Severe hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">9/106 (8.5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3.36 (â2.21 to 8.92)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.65 (0.82 to 3.34)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.56 (0.75 to 3.24)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.23</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Executive function total score, mean (SD) [total No.]<xref rid="zoi221015t4n7" ref-type="table-fn"><sup>g</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1">.19</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10.6 (4.4) [701]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mild hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10.5 (4.5) [377]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â0.07 (â0.63 to 0.48)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â0.01 (â0.54 to 0.57)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.96</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Severe hypoglycemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">9.5 (4.5) [106]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â1.11 (â2.01 to â0.20)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">â0.82 (â1.73 to 0.10)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.08</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <p>Abbreviations: Bayley-III, Bayley Scales of Infant and Toddler Development, Third Edition; MD, mean difference; NA. not applicable; NC, not calculated owing to small numbers; RD, risk difference; RR, risk ratio.</p>
                    <fn id="zoi221015t4n1">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>The severity of hypoglycemia was defined as none (all blood glucose concentrations â¥47 mg/dL), mild (â¥1 episode of â¥36 and &lt;47 mg/dL), and severe (â¥1 episode of &lt;36 mg/dL) (to convert glucose to millimoles per liter, multiply by 0.0555).</p>
                    </fn>
                    <fn id="zoi221015t4n2">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>Adjusted for study site, primary reason for risk of hypoglycemia, socioeconomic decile at birth, and multiple births.</p>
                    </fn>
                    <fn id="zoi221015t4n3">
                      <label>
                        <sup>c</sup>
                      </label>
                      <p><italic>P</italic> value reported is for the overall association between severity of hypoglycemia and outcome, none vs mild, and/or none vs severe.</p>
                    </fn>
                    <fn id="zoi221015t4n4">
                      <label>
                        <sup>d</sup>
                      </label>
                      <p>Defined as any of the following: blindness, hearing impairment requiring aids, moderate or severe cerebral palsy (not walking yet or permanently nonambulant), or moderate or severe developmental delay.</p>
                    </fn>
                    <fn id="zoi221015t4n5">
                      <label>
                        <sup>e</sup>
                      </label>
                      <p>One child in the hypoglycemia group was assigned a score of 49 for the Bayley-III cognitive, language, and motor scales because the child was unable to finish the assessment owing to severe delay. Language, cognitive, and motor scales, mean (100), SD (15), higher scores indicate better performance.</p>
                    </fn>
                    <fn id="zoi221015t4n6">
                      <label>
                        <sup>f</sup>
                      </label>
                      <p>Poor executive function defined as an executive function total score more than 1.5 SD below the mean.</p>
                    </fn>
                    <fn id="zoi221015t4n7">
                      <label>
                        <sup>g</sup>
                      </label>
                      <p>Total score range 0 to 24 points; higher scores indicate better performance. eTable 2 in the <xref rid="note-ZOI221015-1-s" ref-type="supplementary-material">Supplement</xref> presents the executive function component results.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Compared with the normoglycemia group, children who experienced 1 to 2 episodes had a higher risk of neurosensory impairment (23% [99 of 424] vs 18% [125 of 704]; aRR, 1.29; 95% CI, 1.02-1.64) and lower Bayley-III cognitive (mean [SD] 97.5 [11.2] vs 99.0 [11.2]; aMD, â1.80; 95% CI, â3.17 to â0.44) and motor (102.8 [10.0] vs 104.8 [10.8]; aMD, â2.23; 95% CI, â3.53 to â0.92) composite scores (eTable 3 in the <xref rid="note-ZOI221015-1-s" ref-type="supplementary-material">Supplement</xref>). However, children who experienced recurrent episodes did not have a higher risk of neurosensory impairment (19% [12 of 63]; aRR, 1.06; 95% CI, 0.63-1.80) (<xref rid="zoi221015t2" ref-type="table">Table 2</xref>). The frequency of episodes was not associated with moderate or severe neurosensory impairment, cerebral palsy, developmental delay and components, or executive function.</p>
                <p>In post hoc analysis restricted to children who experienced hypoglycemia, there was no interaction between frequency of episodes (1-2 vs recurrent) and treatment (buccal dextrose gel vs intravenous dextrose) with the risk of neurosensory impairment, moderate or severe neurosensory impairment, developmental delay and components, and executive function (eTable 4 in the <xref rid="note-ZOI221015-1-s" ref-type="supplementary-material">Supplement</xref>).</p>
                <p>In subgroup analyses, there was no interaction between hypoglycemia and primary reason for risk of hypoglycemia or infant sex with the risk of neurosensory impairment, moderate or severe neurosensory impairment, and their components (eTable 5 and eTable 6 in the <xref rid="note-ZOI221015-1-s" ref-type="supplementary-material">Supplement</xref>). The findings were not altered after excluding 9 children with postneonatal diagnoses likely to affect the outcome (hypoglycemia group, 1% [3 of 490]; normoglycemia group, 1% [6 of 704]), or 202 children assessed outside the intended assessment window (hypoglycemia group, 16% [76 of 490]; normoglycemia group, 18% [126 of 704]) (eTable 7 and eTable 8 in the <xref rid="note-ZOI221015-1-s" ref-type="supplementary-material">Supplement</xref>). After excluding 425 children whose first language was not English (hypoglycemia, 34% [166 of 490]; normoglycemia, 37% [259 of 704]), the effect size for the primary outcome was little changed but no longer statistically significant (18% [57 of 321] vs 14% [62 of 445]; aRR, 1.26; 95% CI, 0.90-1.76) (eTable 9 in the <xref rid="note-ZOI221015-1-s" ref-type="supplementary-material">Supplement</xref>). After excluding 604 children randomized to prophylactic dextrose gel, the primary outcome findings were similar (47% [229 of 487] vs 53% [375 of 704]; aRR, 1.55; 95% CI, 1.10-2.18) (eTable 10 in the <xref rid="note-ZOI221015-1-s" ref-type="supplementary-material">Supplement</xref>).</p>
              </sec>
            </sec>
            <sec id="H1-4-ZOI221015">
              <title>Discussion</title>
              <p>Children in this cohort study who experienced hypoglycemia were more likely than those who did not to have neurosensory impairment at corrected age 2 years, especially after severe but not recurrent episodes. Children who experienced any hypoglycemia had mean 1- to 2-point lower Bayley-III cognitive and motor scores, and children who experienced severe episodes had 3-point lower motor scores. Although these mean differences are small and unlikely to be of clinical relevance, the 5% absolute difference in overall neurosensory impairment is of more concern.</p>
              <p>Our findings are consistent with previous reports that children who experienced neonatal hypoglycemia, especially severe episodes, were more likely to have poor outcomes, although this outcome has been reported only in later childhood, perhaps because affected skills, such as executive dysfunction and visual and motor impairment, are difficult to test at earlier ages.<sup><xref rid="zoi221015r7" ref-type="bibr">7</xref>,<xref rid="zoi221015r18" ref-type="bibr">18</xref>,<xref rid="zoi221015r19" ref-type="bibr">19</xref></sup> However, we found poorer neurodevelopmental outcomes at corrected age 2 years that were consistent between subgroup and sensitivity analyses.</p>
              <p>One reason for this difference from previous reports may be confounding by neonatal comorbidities. Our cohort comprised well late preterm and full-term neonates without evidence of acute or imminent illness in the first hour after birth, of whom only 8% were later admitted to the NICU, making it easier to distinguish possible effects of hypoglycemia alone. Supporting this finding, to our knowledge, the only other study to detect neurosensory impairments in early childhood after hypoglycemia was a large (nâ=â101 060) population-based study that excluded many infants with other illnesses.<sup><xref rid="zoi221015r18" ref-type="bibr">18</xref></sup> In contrast, the Children With Hypoglycemia and Their Later Development Study reported similar risks of neurosensory impairment between children who did and did not experience hypoglycemia at both age 2 (nâ=â404) and 4.5 (nâ=â477) years.<sup><xref rid="zoi221015r7" ref-type="bibr">7</xref>,<xref rid="zoi221015r20" ref-type="bibr">20</xref></sup> However, that cohort included children born moderately preterm, 4% had other neonatal illnesses as risk factors for hypoglycemia, and 50% had been admitted to the NICU.<sup><xref rid="zoi221015r7" ref-type="bibr">7</xref></sup></p>
              <p>Another possible reason why previous studies have not detected neurodevelopmental impairment at young ages after hypoglycemia may have been limited power. We found relatively small differences between groups in most secondary outcomes (eg, 1-3 points in Bayley scores) and, in the post hoc analysis, for this cohort of 1194 children, the estimated power was 80% to detect a 7% absolute difference in neurosensory impairment between groups (2-tailed testing, Î±â=â.05). Most previous studies included far fewer infants. Furthermore, our inception cohort comprised participants in a randomized clinical trial that specified glucose testing using standard methods and prospective follow-up using standardized assessments.<sup><xref rid="zoi221015r14" ref-type="bibr">14</xref>,<xref rid="zoi221015r15" ref-type="bibr">15</xref></sup> In contrast, some previous studies collected data retrospectively using hospital records, potentially increasing the risk of bias in assessment of exposures and outcomes.<sup><xref rid="zoi221015r9" ref-type="bibr">9</xref>,<xref rid="zoi221015r19" ref-type="bibr">19</xref></sup></p>
              <p>We found that even children who had experienced brief transitional hypoglycemia and were screened and treated with the intention of maintaining blood glucose concentrations greater than or equal to 47 mg/dL are at increased risk of neurodevelopmental impairment. One interpretation could be that current approaches to detection and treatment may ameliorate but not prevent later impairment. Continuous glucose monitoring has shown that neonates screened and treated as in this study spent a mean of 5 of the first 48 hours with interstitial glucose concentrations below the intended threshold.<sup><xref rid="zoi221015r20" ref-type="bibr">20</xref></sup> Furthermore, rapid correction of hypoglycemia and glucose instability after treatment, particularly with intravenous dextrose, have been associated with neurosensory impairment.<sup><xref rid="zoi221015r20" ref-type="bibr">20</xref>,<xref rid="zoi221015r21" ref-type="bibr">21</xref></sup> The widely used treatment threshold of greater than or equal to 47 mg/dL also may not be optimal, although there is minimal reliable evidence about different treatment thresholds.<sup><xref rid="zoi221015r22" ref-type="bibr">22</xref></sup></p>
              <p>It is also possible that hypoglycemia is a marker of neonates who are physiologically vulnerable and at risk of poor outcomes for other reasons.<sup><xref rid="zoi221015r23" ref-type="bibr">23</xref>,<xref rid="zoi221015r24" ref-type="bibr">24</xref>,<xref rid="zoi221015r25" ref-type="bibr">25</xref></sup> This possibility is consistent with the findings in this and other studies that the overall rate of neurodevelopmental impairment is high in children born at risk (19%-48%).<sup><xref rid="zoi221015r7" ref-type="bibr">7</xref>,<xref rid="zoi221015r12" ref-type="bibr">12</xref>,<xref rid="zoi221015r20" ref-type="bibr">20</xref>,<xref rid="zoi221015r26" ref-type="bibr">26</xref>,<xref rid="zoi221015r27" ref-type="bibr">27</xref></sup> Thus, treatment of hypoglycemia may prevent worsening of those outcomes but would not abolish this risk.</p>
              <p>Our secondary analyses suggest that severity of hypoglycemia is more important than frequency for later neurodevelopment, although recurrent episodes were rare (5%), limiting the reliability of this finding. Neurosensory impairment has previously been reported in children who experienced frequent episodes.<sup><xref rid="zoi221015r7" ref-type="bibr">7</xref>,<xref rid="zoi221015r28" ref-type="bibr">28</xref>,<xref rid="zoi221015r29" ref-type="bibr">29</xref></sup> Because the number of episodes likely influences decisions around treatment and intravenous dextrose has been related to glycemic instability,<sup><xref rid="zoi221015r21" ref-type="bibr">21</xref></sup> we explored interactions between the frequency of hypoglycemia and treatment. Among children who experienced hypoglycemia, we found no evidence that neurocognitive outcomes differed between those treated with buccal dextrose gel or with intravenous dextrose, whether experiencing 1 to 2 or recurrent episodes. However, only 33 children were treated with intravenous dextrose, making interactions difficult to detect.</p>
              <p>We found that executive function composite scores were similar between children who did and did not experience hypoglycemia, consistent with a previous report at age 2 years.<sup><xref rid="zoi221015r20" ref-type="bibr">20</xref></sup> However, in that cohort, hypoglycemia was associated with worse executive function at age 4.5 years.<sup><xref rid="zoi221015r7" ref-type="bibr">7</xref></sup> Because executive function is predictive of later academic outcomes<sup><xref rid="zoi221015r30" ref-type="bibr">30</xref></sup> and the overall rate of impairment is high, school-aged follow-up will be important in this and other cohorts.</p>
              <sec id="H2-8-ZOI221015">
                <title>Strengths and Limitations</title>
                <p>This study has strengths. The cohort was large and the follow-up rate was high at 91%. Data were collected prospectively and analyses were adjusted for known confounders. Because this was a cohort analysis of a randomized trial, there were consistent study entry criteria, excluding neonates with acute or imminent illnesses at 1 hour after birth.</p>
                <p>This study also has limitations. First, the design was observational, so residual confounding was possible. Second, some findings may reflect type I errors because we did not adjust for multiplicity. Third, we did not use continuous glucose monitoring to more accurately detect the frequency of hypoglycemia.<sup><xref rid="zoi221015r31" ref-type="bibr">31</xref>,<xref rid="zoi221015r32" ref-type="bibr">32</xref></sup> Fourth, although use of Bayley-III is reliable in detecting early developmental delays,<sup><xref rid="zoi221015r14" ref-type="bibr">14</xref></sup> it is less accurate to estimate later cognitive and motor functioning.<sup><xref rid="zoi221015r33" ref-type="bibr">33</xref>,<xref rid="zoi221015r34" ref-type="bibr">34</xref>,<xref rid="zoi221015r35" ref-type="bibr">35</xref></sup></p>
              </sec>
            </sec>
            <sec id="H1-5-ZOI221015">
              <title>Conclusions</title>
              <p>In this study, children born at risk but otherwise well who experienced neonatal hypoglycemia were more likely than those who did not to have neurosensory impairment at corrected age 2 years, with higher risks after severe episodes. Future studies should be large, consider confounding neonatal illnesses, and follow up children prospectively using individual assessments. Further research is also important to establish whether this association is causal and whether these early findings persist at school age.</p>
            </sec>
          </body>
          <back>
            <ref-list id="REF-ZOI221015">
              <title>References</title>
              <ref id="zoi221015r1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Hay</surname><given-names>WW</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Raju</surname><given-names>TNK</given-names></string-name>, <string-name><surname>Higgins</surname><given-names>RD</given-names></string-name>, <string-name><surname>Kalhan</surname><given-names>SC</given-names></string-name>, <string-name><surname>Devaskar</surname><given-names>SU</given-names></string-name></person-group>. <article-title>Knowledge gaps and research needs for understanding and treating neonatal hypoglycemia: workshop report from Eunice Kennedy Shriver National Institute of Child Health and Human Development</article-title>. <source>J Pediatr</source>. <year>2009</year>;<volume>155</volume>(<issue>5</issue>):<fpage>612</fpage>-<lpage>617</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpeds.2009.06.044</pub-id><?supplied-pmid 19840614?><pub-id pub-id-type="pmid">19840614</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Harris</surname><given-names>DL</given-names></string-name>, <string-name><surname>Weston</surname><given-names>PJ</given-names></string-name>, <string-name><surname>Harding</surname><given-names>JE</given-names></string-name></person-group>. <article-title>Incidence of neonatal hypoglycemia in babies identified as at risk</article-title>. <source>J Pediatr</source>. <year>2012</year>;<volume>161</volume>(<issue>5</issue>):<fpage>787</fpage>-<lpage>791</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpeds.2012.05.022</pub-id><?supplied-pmid 22727868?><pub-id pub-id-type="pmid">22727868</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Burns</surname><given-names>CM</given-names></string-name>, <string-name><surname>Rutherford</surname><given-names>MA</given-names></string-name>, <string-name><surname>Boardman</surname><given-names>JP</given-names></string-name>, <string-name><surname>Cowan</surname><given-names>FM</given-names></string-name></person-group>. <article-title>Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia</article-title>. <source>Pediatrics</source>. <year>2008</year>;<volume>122</volume>(<issue>1</issue>):<fpage>65</fpage>-<lpage>74</lpage>. doi:<pub-id pub-id-type="doi">10.1542/peds.2007-2822</pub-id><?supplied-pmid 18595988?><pub-id pub-id-type="pmid">18595988</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Filan</surname><given-names>PM</given-names></string-name>, <string-name><surname>Inder</surname><given-names>TE</given-names></string-name>, <string-name><surname>Cameron</surname><given-names>FJ</given-names></string-name>, <string-name><surname>Kean</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Hunt</surname><given-names>RW</given-names></string-name></person-group>. <article-title>Neonatal hypoglycemia and occipital cerebral injury</article-title>. <source>J Pediatr</source>. <year>2006</year>;<volume>148</volume>(<issue>4</issue>):<fpage>552</fpage>-<lpage>555</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpeds.2005.11.015</pub-id><?supplied-pmid 16647423?><pub-id pub-id-type="pmid">16647423</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Boluyt</surname><given-names>N</given-names></string-name>, <string-name><surname>van Kempen</surname><given-names>A</given-names></string-name>, <string-name><surname>Offringa</surname><given-names>M</given-names></string-name></person-group>. <article-title>Neurodevelopment after neonatal hypoglycemia: a systematic review and design of an optimal future study</article-title>. <source>Pediatrics</source>. <year>2006</year>;<volume>117</volume>(<issue>6</issue>):<fpage>2231</fpage>-<lpage>2243</lpage>. doi:<pub-id pub-id-type="doi">10.1542/peds.2005-1919</pub-id><?supplied-pmid 16740869?><pub-id pub-id-type="pmid">16740869</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Shah</surname><given-names>R</given-names></string-name>, <string-name><surname>Harding</surname><given-names>J</given-names></string-name>, <string-name><surname>Brown</surname><given-names>J</given-names></string-name>, <string-name><surname>McKinlay</surname><given-names>C</given-names></string-name></person-group>. <article-title>Neonatal glycaemia and neurodevelopmental outcomes: a systematic review and meta-analysis</article-title>. <source>Neonatology</source>. <year>2019</year>;<volume>115</volume>(<issue>2</issue>):<fpage>116</fpage>-<lpage>126</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000492859</pub-id><?supplied-pmid 30408811?><pub-id pub-id-type="pmid">30408811</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>McKinlay</surname><given-names>CJD</given-names></string-name>, <string-name><surname>Alsweiler</surname><given-names>JM</given-names></string-name>, <string-name><surname>Anstice</surname><given-names>NS</given-names></string-name>, <etal/>; <collab>Children With Hypoglycemia and Their Later Development (CHYLD) Study Team</collab></person-group>. <article-title>Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years</article-title>. <source>JAMA Pediatr</source>. <year>2017</year>;<volume>171</volume>(<issue>10</issue>):<fpage>972</fpage>-<lpage>983</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamapediatrics.2017.1579</pub-id><?supplied-pmid 28783802?><pub-id pub-id-type="pmid">28783802</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Qiao</surname><given-names>LX</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name><surname>Yan</surname><given-names>JH</given-names></string-name>, <etal/></person-group>. <article-title>Follow-up study of neurodevelopment in 2-year-old infants who had suffered from neonatal hypoglycemia</article-title>. <source>BMC Pediatr</source>. <year>2019</year>;<volume>19</volume>(<issue>1</issue>):<fpage>133</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12887-019-1509-4</pub-id><?supplied-pmid 31023291?><pub-id pub-id-type="pmid">31023291</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Rasmussen</surname><given-names>AH</given-names></string-name>, <string-name><surname>Wehberg</surname><given-names>S</given-names></string-name>, <string-name><surname>PÃ¸rtner</surname><given-names>F</given-names></string-name>, <string-name><surname>Larsen</surname><given-names>AM</given-names></string-name>, <string-name><surname>Filipsen</surname><given-names>K</given-names></string-name>, <string-name><surname>Christesen</surname><given-names>HT</given-names></string-name></person-group>. <article-title>Neurodevelopmental outcomes after moderate to severe neonatal hypoglycemia</article-title>. <source>Eur J Pediatr</source>. <year>2020</year>;<volume>179</volume>(<issue>12</issue>):<fpage>1981</fpage>-<lpage>1991</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00431-020-03729-x</pub-id><?supplied-pmid 32666280?><pub-id pub-id-type="pmid">32666280</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Harding</surname><given-names>JE</given-names></string-name>, <string-name><surname>Hegarty</surname><given-names>JE</given-names></string-name>, <string-name><surname>Crowther</surname><given-names>CA</given-names></string-name>, <string-name><surname>Edlin</surname><given-names>R</given-names></string-name>, <string-name><surname>Gamble</surname><given-names>G</given-names></string-name>, <string-name><surname>Alsweiler</surname><given-names>JM</given-names></string-name></person-group>. <article-title>Randomised trial of neonatal Hypoglycaemia Prevention With Oral Dextrose Gel (hPOD): study protocol</article-title>. <source>BMC Pediatr</source>. <year>2015</year>;<volume>15</volume>(<issue>120</issue>):<fpage>120</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12887-015-0440-6</pub-id><?supplied-pmid 26377909?><pub-id pub-id-type="pmid">26377909</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Harding</surname><given-names>JE</given-names></string-name>, <string-name><surname>Hegarty</surname><given-names>JE</given-names></string-name>, <string-name><surname>Crowther</surname><given-names>CA</given-names></string-name>, <string-name><surname>Edlin</surname><given-names>RP</given-names></string-name>, <string-name><surname>Gamble</surname><given-names>GD</given-names></string-name>, <string-name><surname>Alsweiler</surname><given-names>JM</given-names></string-name>; <collab>hPOD Study Group</collab></person-group>. <article-title>Evaluation of oral dextrose gel for prevention of neonatal hypoglycemia (hPOD): a multicenter, double-blind randomized controlled trial</article-title>. <source>PLoS Med</source>. <year>2021</year>;<volume>18</volume>(<issue>1</issue>):<elocation-id>e1003411</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pmed.1003411</pub-id><?supplied-pmid 33507929?><pub-id pub-id-type="pmid">33507929</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Edwards</surname><given-names>T</given-names></string-name>, <string-name><surname>Alsweiler</surname><given-names>JM</given-names></string-name>, <string-name><surname>Crowther</surname><given-names>CA</given-names></string-name>, <etal/></person-group>. <article-title>Prophylactic oral dextrose gel and neurosensory impairment at 2-year follow-up of participants in the hPOD randomized trial</article-title>. <source>JAMA</source>. <year>2022</year>;<volume>327</volume>(<issue>12</issue>):<fpage>1149</fpage>-<lpage>1157</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2022.2363</pub-id><?supplied-pmid 35315885?><pub-id pub-id-type="pmid">35315885</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Rajay</surname><given-names>AB</given-names></string-name>, <string-name><surname>Harding</surname><given-names>JE</given-names></string-name>; <collab>hPOD Study Group</collab></person-group>. <article-title>Variations in New Zealand and Australian guidelines for the management of neonatal hypoglycaemia: a secondary analysis from the Hypoglycaemia Prevention With Oral Dextrose Gel trial (hPOD)</article-title>. <source>J Paediatr Child Health</source>. <year>2022</year>;<volume>58</volume>(<issue>5</issue>):<fpage>820</fpage>-<lpage>829</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jpc.15846</pub-id><?supplied-pmid 34866258?><pub-id pub-id-type="pmid">34866258</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r14">
                <label>14</label>
                <mixed-citation publication-type="book"><person-group><string-name><surname>Bayley</surname><given-names>N</given-names></string-name></person-group>. <source>Bayley Scales of Infant and Toddler Development</source>. <edition>3rd ed</edition>. <publisher-name>Harcourt Assessment</publisher-name>; <year>2006</year>.</mixed-citation>
              </ref>
              <ref id="zoi221015r15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Ansell</surname><given-names>JM</given-names></string-name>, <string-name><surname>Wouldes</surname><given-names>TA</given-names></string-name>, <string-name><surname>Harding</surname><given-names>JE</given-names></string-name>; <collab>CHYLD Study group</collab></person-group>. <article-title>Executive function assessment in New Zealand 2-year olds born at risk of neonatal hypoglycemia</article-title>. <source>PLoS One</source>. <year>2017</year>;<volume>12</volume>(<issue>11</issue>):<elocation-id>e0188158</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0188158</pub-id><?supplied-pmid 29166407?><pub-id pub-id-type="pmid">29166407</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r16">
                <label>16</label>
                <mixed-citation publication-type="book"><person-group><string-name><surname>Atkinson</surname><given-names>J</given-names></string-name>, <string-name><surname>Salmond</surname><given-names>C</given-names></string-name>, <string-name><surname>Crampton</surname><given-names>P</given-names></string-name></person-group>. <source>NZDep2018 Index of Deprivation, Interim Research Report, December 2019</source>. <publisher-name>University of Otago</publisher-name>; <year>2019</year>.</mixed-citation>
              </ref>
              <ref id="zoi221015r17">
                <label>17</label>
                <mixed-citation publication-type="webpage">Stats NZ. Ethnicity New Zealand Standard Classification <year>2005</year> V2.1.0. Accessed September 3, 2021. <ext-link xlink:href="https://bit.ly/3MkvJrZ" ext-link-type="uri">https://bit.ly/3MkvJrZ</ext-link></mixed-citation>
              </ref>
              <ref id="zoi221015r18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>WickstrÃ¶m</surname><given-names>R</given-names></string-name>, <string-name><surname>SkiÃ¶ld</surname><given-names>B</given-names></string-name>, <string-name><surname>Petersson</surname><given-names>G</given-names></string-name>, <string-name><surname>Stephansson</surname><given-names>O</given-names></string-name>, <string-name><surname>Altman</surname><given-names>M</given-names></string-name></person-group>. <article-title>Moderate neonatal hypoglycemia and adverse neurological development at 2-6 years of age</article-title>. <source>Eur J Epidemiol</source>. <year>2018</year>;<volume>33</volume>(<issue>10</issue>):<fpage>1011</fpage>-<lpage>1020</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10654-018-0425-5</pub-id><?supplied-pmid 30030683?><pub-id pub-id-type="pmid">30030683</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Kaiser</surname><given-names>JR</given-names></string-name>, <string-name><surname>Bai</surname><given-names>S</given-names></string-name>, <string-name><surname>Gibson</surname><given-names>N</given-names></string-name>, <etal/></person-group>. <article-title>Association between transient newborn hypoglycemia and fourth-grade achievement test proficiency: a population-based study</article-title>. <source>JAMA Pediatr</source>. <year>2015</year>;<volume>169</volume>(<issue>10</issue>):<fpage>913</fpage>-<lpage>921</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamapediatrics.2015.1631</pub-id><?supplied-pmid 26301959?><pub-id pub-id-type="pmid">26301959</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>McKinlay</surname><given-names>CJD</given-names></string-name>, <string-name><surname>Alsweiler</surname><given-names>JM</given-names></string-name>, <string-name><surname>Ansell</surname><given-names>JM</given-names></string-name>, <etal/>; <collab>CHYLD Study Group</collab></person-group>. <article-title>Neonatal glycemia and neurodevelopmental outcomes at 2 years</article-title>. <source>N Engl J Med</source>. <year>2015</year>;<volume>373</volume>(<issue>16</issue>):<fpage>1507</fpage>-<lpage>1518</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa1504909</pub-id><?supplied-pmid 26465984?><pub-id pub-id-type="pmid">26465984</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Burakevych</surname><given-names>N</given-names></string-name>, <string-name><surname>McKinlay</surname><given-names>CJD</given-names></string-name>, <string-name><surname>Harris</surname><given-names>DL</given-names></string-name>, <string-name><surname>Alsweiler</surname><given-names>JM</given-names></string-name>, <string-name><surname>Harding</surname><given-names>JE</given-names></string-name></person-group>. <article-title>Factors influencing glycaemic stability after neonatal hypoglycaemia and relationship to neurodevelopmental outcome</article-title>. <source>Sci Rep</source>. <year>2019</year>;<volume>9</volume>(<issue>1</issue>):<fpage>8132</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-019-44609-1</pub-id><?supplied-pmid 31148566?><pub-id pub-id-type="pmid">31148566</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>van Kempen</surname><given-names>AAMW</given-names></string-name>, <string-name><surname>Eskes</surname><given-names>PF</given-names></string-name>, <string-name><surname>Nuytemans</surname><given-names>DHGM</given-names></string-name>, <etal/>; <collab>HypoEXIT Study Group</collab></person-group>. <article-title>Lower versus traditional treatment threshold for neonatal hypoglycemia</article-title>. <source>N Engl J Med</source>. <year>2020</year>;<volume>382</volume>(<issue>6</issue>):<fpage>534</fpage>-<lpage>544</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa1905593</pub-id><?supplied-pmid 32023373?><pub-id pub-id-type="pmid">32023373</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Woythaler</surname><given-names>MA</given-names></string-name>, <string-name><surname>McCormick</surname><given-names>MC</given-names></string-name>, <string-name><surname>Smith</surname><given-names>VC</given-names></string-name></person-group>. <article-title>Late preterm infants have worse 24-month neurodevelopmental outcomes than term infants</article-title>. <source>Pediatrics</source>. <year>2011</year>;<volume>127</volume>(<issue>3</issue>):<fpage>e622</fpage>-<lpage>e629</lpage>. doi:<pub-id pub-id-type="doi">10.1542/peds.2009-3598</pub-id><?supplied-pmid 21321024?><pub-id pub-id-type="pmid">21321024</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Christian</surname><given-names>P</given-names></string-name>, <string-name><surname>Murray-Kolb</surname><given-names>LE</given-names></string-name>, <string-name><surname>Tielsch</surname><given-names>JM</given-names></string-name>, <string-name><surname>Katz</surname><given-names>J</given-names></string-name>, <string-name><surname>LeClerq</surname><given-names>SC</given-names></string-name>, <string-name><surname>Khatry</surname><given-names>SK</given-names></string-name></person-group>. <article-title>Associations between preterm birth, small-for-gestational age, and neonatal morbidity and cognitive function among school-age children in Nepal</article-title>. <source>BMC Pediatr</source>. <year>2014</year>;<volume>14</volume>(<issue>58</issue>):<fpage>58</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-2431-14-58</pub-id><?supplied-pmid 24575933?><pub-id pub-id-type="pmid">24575933</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Silverman</surname><given-names>BL</given-names></string-name>, <string-name><surname>Rizzo</surname><given-names>T</given-names></string-name>, <string-name><surname>Green</surname><given-names>OC</given-names></string-name>, <etal/></person-group>. <article-title>Long-term prospective evaluation of offspring of diabetic mothers</article-title>. <source>Diabetes</source>. <year>1991</year>;<volume>40</volume>(<issue>suppl 2</issue>):<fpage>121</fpage>-<lpage>125</lpage>. doi:<pub-id pub-id-type="doi">10.2337/diab.40.2.S121</pub-id><?supplied-pmid 1748240?><pub-id pub-id-type="pmid">1748240</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Griffith</surname><given-names>R</given-names></string-name>, <string-name><surname>Hegarty</surname><given-names>J</given-names></string-name>, <string-name><surname>Alsweiler</surname><given-names>J</given-names></string-name>, <etal/></person-group>. <article-title>Two-year outcomes after dextrose gel prophylaxis for neonatal hypoglycaemia</article-title>. <source>Arch Dis Child Fetal Neonatal Ed</source>. <year>2021</year>;<volume>106</volume>(<issue>3</issue>):<fpage>278</fpage>-<lpage>285</lpage>. doi:<pub-id pub-id-type="doi">10.1136/archdischild-2020-320305</pub-id><?supplied-pmid 33148686?><pub-id pub-id-type="pmid">33148686</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Shah</surname><given-names>R</given-names></string-name>, <string-name><surname>Dai</surname><given-names>DWT</given-names></string-name>, <string-name><surname>Alsweiler</surname><given-names>JM</given-names></string-name>, <etal/>; <collab>Children With Hypoglycaemia and Their Later Development (CHYLD) Study Team</collab></person-group>. <article-title>Association of neonatal hypoglycemia with academic performance in mid-childhood</article-title>. <source>JAMA</source>. <year>2022</year>;<volume>327</volume>(<issue>12</issue>):<fpage>1158</fpage>-<lpage>1170</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2022.0992</pub-id><?supplied-pmid 35315886?><pub-id pub-id-type="pmid">35315886</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Duvanel</surname><given-names>CB</given-names></string-name>, <string-name><surname>Fawer</surname><given-names>CL</given-names></string-name>, <string-name><surname>Cotting</surname><given-names>J</given-names></string-name>, <string-name><surname>Hohlfeld</surname><given-names>P</given-names></string-name>, <string-name><surname>Matthieu</surname><given-names>JM</given-names></string-name></person-group>. <article-title>Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-for-gestational-age preterm infants</article-title>. <source>J Pediatr</source>. <year>1999</year>;<volume>134</volume>(<issue>4</issue>):<fpage>492</fpage>-<lpage>498</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0022-3476(99)70209-X</pub-id><?supplied-pmid 10190926?><pub-id pub-id-type="pmid">10190926</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r29">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lucas</surname><given-names>A</given-names></string-name>, <string-name><surname>Morley</surname><given-names>R</given-names></string-name>, <string-name><surname>Cole</surname><given-names>TJ</given-names></string-name></person-group>. <article-title>Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia</article-title>. <source>BMJ</source>. <year>1988</year>;<volume>297</volume>(<issue>6659</issue>):<fpage>1304</fpage>-<lpage>1308</lpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.297.6659.1304</pub-id><?supplied-pmid 2462455?><pub-id pub-id-type="pmid">2462455</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r30">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Dai</surname><given-names>DWT</given-names></string-name>, <string-name><surname>Wouldes</surname><given-names>TA</given-names></string-name>, <string-name><surname>Brown</surname><given-names>GTL</given-names></string-name>, <etal/>; <collab>Piano Study Group</collab></person-group>. <article-title>Relationships between intelligence, executive function and academic achievement in children born very preterm</article-title>. <source>Early Hum Dev</source>. <year>2020</year>;<volume>148</volume>(<issue>105122</issue>):<elocation-id>105122</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.earlhumdev.2020.105122</pub-id><?supplied-pmid 32679472?><pub-id pub-id-type="pmid">32679472</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r31">
                <label>31</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Hegarty</surname><given-names>JE</given-names></string-name>, <string-name><surname>Alsweiler</surname><given-names>JM</given-names></string-name>, <string-name><surname>Gamble</surname><given-names>GG</given-names></string-name>, <string-name><surname>Crowther</surname><given-names>CA</given-names></string-name>, <string-name><surname>Harding</surname><given-names>JE</given-names></string-name></person-group>. <article-title>Effect of prophylactic dextrose gel on continuous measures of neonatal glycemia: secondary analysis of the pre-hPOD trial</article-title>. <source>J Pediatr</source>. <year>2021</year>;<volume>235</volume>:<fpage>107</fpage>-<lpage>115.e4</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpeds.2021.03.057</pub-id><?supplied-pmid 33798509?><pub-id pub-id-type="pmid">33798509</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r32">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Uettwiller</surname><given-names>F</given-names></string-name>, <string-name><surname>Chemin</surname><given-names>A</given-names></string-name>, <string-name><surname>Bonnemaison</surname><given-names>E</given-names></string-name>, <string-name><surname>Favrais</surname><given-names>G</given-names></string-name>, <string-name><surname>Saliba</surname><given-names>E</given-names></string-name>, <string-name><surname>Labarthe</surname><given-names>F</given-names></string-name></person-group>. <article-title>Real-time continuous glucose monitoring reduces the duration of hypoglycemia episodes: a randomized trial in very low birth weight neonates</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>(<issue>1</issue>):<elocation-id>e0116255</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0116255</pub-id><?supplied-pmid 25590334?><pub-id pub-id-type="pmid">25590334</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r33">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Burakevych</surname><given-names>N</given-names></string-name>, <string-name><surname>Mckinlay</surname><given-names>CJD</given-names></string-name>, <string-name><surname>Alsweiler</surname><given-names>JM</given-names></string-name>, <string-name><surname>Wouldes</surname><given-names>TA</given-names></string-name>, <string-name><surname>Harding</surname><given-names>JE</given-names></string-name>; <collab>Chyld Study Team</collab></person-group>. <article-title>Bayley-III motor scale and neurological examination at 2 years do not predict motor skills at 4.5 years</article-title>. <source>Dev Med Child Neurol</source>. <year>2017</year>;<volume>59</volume>(<issue>2</issue>):<fpage>216</fpage>-<lpage>223</lpage>. doi:<pub-id pub-id-type="doi">10.1111/dmcn.13232</pub-id><?supplied-pmid 27543144?><pub-id pub-id-type="pmid">27543144</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r34">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Spittle</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Spencer-Smith</surname><given-names>MM</given-names></string-name>, <string-name><surname>Eeles</surname><given-names>AL</given-names></string-name>, <etal/></person-group>. <article-title>Does the Bayley-III Motor Scale at 2 years predict motor outcome at 4 years in very preterm children?</article-title><source>Dev Med Child Neurol</source>. <year>2013</year>;<volume>55</volume>(<issue>5</issue>):<fpage>448</fpage>-<lpage>452</lpage>. doi:<pub-id pub-id-type="doi">10.1111/dmcn.12049</pub-id><?supplied-pmid 23216518?><pub-id pub-id-type="pmid">23216518</pub-id></mixed-citation>
              </ref>
              <ref id="zoi221015r35">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Spencer-Smith</surname><given-names>MM</given-names></string-name>, <string-name><surname>Spittle</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Lee</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Doyle</surname><given-names>LW</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>PJ</given-names></string-name></person-group>. <article-title>Bayley-III cognitive and language scales in preterm children</article-title>. <source>Pediatrics</source>. <year>2015</year>;<volume>135</volume>(<issue>5</issue>):<fpage>e1258</fpage>-<lpage>e1265</lpage>. doi:<pub-id pub-id-type="doi">10.1542/peds.2014-3039</pub-id><?supplied-pmid 25896835?><pub-id pub-id-type="pmid">25896835</pub-id></mixed-citation>
              </ref>
            </ref-list>
            <notes notes-type="supplementary-material" id="note-ZOI221015-1">
              <supplementary-material id="note-ZOI221015-1-s" position="float" content-type="local-data">
                <label>Supplement.</label>
                <caption>
                  <p><bold>eTable 1.</bold> Maternal and Infant Characteristics of Those Included and Not Included in This Analysis</p>
                  <p><bold>eTable 2.</bold> Associations Between Neonatal Hypoglycemia and Its Severity and Performance-Based Executive Function Tasks at 2 Years</p>
                  <p><bold>eTable 3.</bold> Associations Between Frequency of Neonatal Hypoglycemia and Neurocognitive Outcomes at 2 Years</p>
                  <p><bold>eTable 4.</bold> Interaction Between Treatment and the Relationship Between Frequency of Hypoglycemia and Neurocognitive Outcomes at 2 Years</p>
                  <p><bold>eTable 5.</bold> Selected Neurocognitive Outcomes in Children Who Did and Did Not Experience Hypoglycemia Who Had Different Primary Reasons for Risk of Hypoglycemia (Subgroup Analysis)</p>
                  <p><bold>eTable 6.</bold> Selected Neurocognitive Outcomes in Boys and Girls Who Did and Did Not Experience Hypoglycemia (Subgroup Analysis)</p>
                  <p><bold>eTable 7.</bold> Selected Neurocognitive Outcomes in Children Who Did and Did Not Experience Hypoglycemia, Excluding Children With Postneonatal Diagnoses Likely to Affect the Outcome (Sensitivity Analysis)</p>
                  <p><bold>eTable 8.</bold> Selected Neurocognitive Outcomes in Children Who Did and Did Not Experience Hypoglycemia, Excluding Children Assessed Outside of the Intended Assessment Window of 23 to 25 Months' Corrected Age (Sensitivity Analysis)</p>
                  <p><bold>eTable 9.</bold> Selected Neurocognitive Outcomes in Children Who Did and Did Not Experience Hypoglycemia, Excluding Children Whose First Language Was Not English (Sensitivity Analysis)</p>
                  <p><bold>eTable 10.</bold> The Primary Outcome of Neurosensory Impairment in Children Who Did and Did Not Experience Hypoglycemia, Excluding Children Randomized to Prophylactic Buccal Dextrose Gel (Sensitivity Analysis)</p>
                </caption>
                <media xlink:href="jamanetwopen-e2235989-s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </notes>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
